Timothy P. Walbert - 28 Jan 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Jan 2022
Net transactions value
-$10,881,483
Form type
4
Filing time
31 Jan 2022, 16:26:25 UTC
Previous filing
24 Jan 2022
Next filing
02 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $553,500 +25,000 +3.6% $22.14* 710,549 28 Jan 2022 Direct
transaction HZNP Ordinary Shares Sale $2,250,000 -25,000 -3.5% $90.00 685,549 28 Jan 2022 Direct F1
transaction HZNP Ordinary Shares Sale $1,322,504 -14,541 -2.1% $90.95 671,008 31 Jan 2022 Direct F1, F2
transaction HZNP Ordinary Shares Sale $6,826,821 -74,253 -11% $91.94 596,755 31 Jan 2022 Direct F1, F3
transaction HZNP Ordinary Shares Sale $1,035,659 -11,206 -1.9% $92.42 585,549 31 Jan 2022 Direct F1, F4
holding HZNP Ordinary Shares 107,739 28 Jan 2022 See footnote F5
holding HZNP Ordinary Shares 100,300 28 Jan 2022 See footnote F6
holding HZNP Ordinary Shares 35,603 28 Jan 2022 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -25,000 -2.5% $0.000000 967,565 28 Jan 2022 Ordinary Shares 25,000 $22.14 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.32 to $91.305 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.34 to $92.335 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.34 to $92.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F6 The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F7 The stock option is fully vested and exercisable.